NuCyRNA Therapeutics
NuCyRNA Therapeutics

Pagliuca Harvard Life Lab

NuCyRNA Therapeutics

Redefining RNA-targeting therapeutics, starting in neurodegenerative diseases.
Nucyrna team lead

Founders

Feng (Damon) Wang

Harvard University

Joseph Klim

Harvard Medical School

About NuCyRNA Therapeutics

School

Harvard University, Harvard Medical School

Lab

Pagliuca Harvard Life Lab

Programs

Pagliuca Harvard Life Lab

Connect

Email, Website, LinkedIn

Watch NuCyRNA Therapeutics pitch at the 2026 President’s Innovation Challenge

Awards & Affiliations

  • 2026

    President's Innovation Challenge Finalist

    Alumni + Affiliates Health Care + Life Sciences Track

  • 2025

    President's Innovation Challenge Finalist

    Alumni + Affiliates Health Care + Life Sciences Track

More Pagliuca Harvard Life Lab Ventures